(GTT) Gaztransport & Technigaz SAS - Overview
Sector: EnergyIndustry: Oil & Gas Equipment & Services | Exchange PA (France) | Currency EUR | Market Cap: 8.648m | Total Return 48% in 12m
Stock: Gas Storage, Gas Transport, Engineering, Technology
| Risk 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.68 |
| Alpha | 46.16 |
| Character TTM | |
|---|---|
| Beta | 0.280 |
| Beta Downside | 0.513 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.67% |
| CAGR/Max DD | 1.61 |
Description: GTT Gaztransport & Technigaz SAS March 05, 2026
Gaztransport & Technigaz SA (GTT) is a French engineering company specializing in cryogenic membrane containment systems for liquefied gases. These systems are critical for the safe and efficient global transport and storage of substances like LNG, a key energy source.
GTT operates in two segments: Core Business and Hydrogen. The Core Business focuses on containment solutions for maritime transport and onshore/offshore storage of various liquefied gases, including LNG, ethane, and propane. This sector is characterized by long lead times for vessel construction and high capital expenditure.
The company also provides consultancy, engineering, and maintenance services for its systems. GTTs business model relies on intellectual property and licensing agreements with shipyards, gas companies, and terminal operators.
The Hydrogen segment involves designing and assembling electrolyzers for green hydrogen production and adapting containment technology for LNG-fueled vessels. The nascent hydrogen economy presents a new growth area for GTTs specialized containment expertise.
Further research on ValueRay can provide detailed financial metrics and competitive analysis.
Headlines to watch out for
- Global LNG demand growth drives containment system orders
- Shipbuilding activity in Asia impacts order book
- Regulatory changes for maritime emissions boost LNG fuel
- Hydrogen segment expansion offers future revenue diversification
- Raw material costs for cryogenic systems affect margins
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 761.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.66 > 0.02 and ΔFCF/TA 22.68 > 1.0 |
| NWC/Revenue: 23.37% < 20% (prev 37.24%; Δ -13.87% < -1%) |
| CFO/TA 0.76 > 3% & CFO 798.3m > Net Income 761.4m |
| Net Debt (-218.0m) to EBITDA (912.7m): -0.24 < 3 |
| Current Ratio: 2.0 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.2m) vs 12m ago 0.13% < -2% |
| Gross Margin: 80.19% > 18% (prev 0.63%; Δ 7.96k% > 0.5%) |
| Asset Turnover: 173.8% > 50% (prev 109.1%; Δ 64.72% > 0%) |
| Interest Coverage Ratio: 7.23k > 6 (EBITDA TTM 912.7m / Interest Expense TTM 84.0k) |
Altman Z'' 10.00
| A: 0.32 (Total Current Assets 675.2m - Total Current Liabilities 337.6m) / Total Assets 1.05b |
| B: 0.56 (Retained Earnings 585.6m / Total Assets 1.05b) |
| C: 0.73 (EBIT TTM 606.9m / Avg Total Assets 831.1m) |
| D: 1.28 (Book Value of Equity 586.0m / Total Liabilities 456.1m) |
| Altman-Z'' Score: 10.20 = AAA |
Beneish M -1.46
| DSRI: 0.57 (Receivables 259.6m/212.2m, Revenue 1.44b/672.3m) |
| GMI: 0.78 (GM 80.19% / 62.73%) |
| AQI: 3.25 (AQ_t 0.29 / AQ_t-1 0.09) |
| SGI: 2.15 (Revenue 1.44b / 672.3m) |
| TATA: -0.04 (NI 761.4m - CFO 798.3m) / TA 1.05b) |
| Beneish M-Score: -1.46 (Cap -4..+1) = D |
What is the price of GTT shares?
Over the past week, the price has changed by -3.49%, over one month by +6.56%, over three months by +30.95% and over the past year by +48.01%.
Is GTT a buy, sell or hold?
What are the forecasts/targets for the GTT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 197.6 | -3.5% |
| Analysts Target Price | - | - |
GTT Fundamental Data Overview March 25, 2026
P/E Trailing = 18.1475
P/E Forward = 21.1416
P/S = 9.3146
P/B = 12.8421
Revenue TTM = 1.44b EUR
EBIT TTM = 606.9m EUR
EBITDA TTM = 912.7m EUR
Long Term Debt = 88.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 40.3m EUR (from shortTermDebt, last quarter)
Debt = 128.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -218.0m EUR (from netDebt column, last quarter)
Enterprise Value = 7.26b EUR (7.48b + Debt 128.7m - CCE 346.7m)
Interest Coverage Ratio = 7.23k (Ebit TTM 606.9m / Interest Expense TTM 84.0k)
EV/FCF = 10.48x (Enterprise Value 7.26b / FCF TTM 693.2m)
FCF Yield = 9.55% (FCF TTM 693.2m / Enterprise Value 7.26b)
FCF Margin = 47.99% (FCF TTM 693.2m / Revenue TTM 1.44b)
Net Margin = 52.71% (Net Income TTM 761.4m / Revenue TTM 1.44b)
Gross Margin = 80.19% ((Revenue TTM 1.44b - Cost of Revenue TTM 286.1m) / Revenue TTM)
Gross Margin QoQ = 65.00% (prev 70.93%)
Tobins Q-Ratio = 6.94 (Enterprise Value 7.26b / Total Assets 1.05b)
Interest Expense / Debt = 0.07% (Interest Expense 84.0k / Debt 128.7m)
Taxrate = 13.27% (35.7m / 269.3m)
NOPAT = 526.4m (EBIT 606.9m * (1 - 13.27%))
Current Ratio = 2.0 (Total Current Assets 675.2m / Total Current Liabilities 337.6m)
Debt / Equity = 0.22 (Debt 128.7m / totalStockholderEquity, last quarter 588.2m)
Debt / EBITDA = -0.24 (Net Debt -218.0m / EBITDA 912.7m)
Debt / FCF = -0.31 (Net Debt -218.0m / FCF TTM 693.2m)
Total Stockholder Equity = 492.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 91.61% (Net Income 761.4m / Total Assets 1.05b)
RoE = 154.6% (Net Income TTM 761.4m / Total Stockholder Equity 492.5m)
RoCE = 104.5% (EBIT 606.9m / Capital Employed (Equity 492.5m + L.T.Debt 88.4m))
RoIC = 106.9% (NOPAT 526.4m / Invested Capital 492.5m)
WACC = 6.85% (E(7.48b)/V(7.61b) * Re(6.97%) + D(128.7m)/V(7.61b) * Rd(0.07%) * (1-Tc(0.13)))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.07%
[DCF] Terminal Value 85.44% ; FCFF base≈523.4m ; Y1≈645.7m ; Y5≈1.10b
[DCF] Fair Price = 673.5 (EV 24.74b - Net Debt -218.0m = Equity 24.96b / Shares 37.1m; r=6.85% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -4.62 | EPS CAGR: -74.28% | SUE: 0.0 | # QB: 0
Revenue Correlation: 76.59 | Revenue CAGR: 39.68% | SUE: -0.04 | # QB: 0
EPS current Year (2026-12-31): EPS=11.45 | Chg7d=+0.000 | Chg30d=+0.071 | Revisions Net=-3 | Growth EPS=+3.0% | Growth Revenue=-4.2%
EPS next Year (2027-12-31): EPS=11.70 | Chg7d=+0.000 | Chg30d=+0.326 | Revisions Net=+4 | Growth EPS=+2.1% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: -0.33 (3 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 7.9% - Earnings Yield 5.5%)
[Growth] Growth Spread = +1.7% (Analyst 4.2% - Implied 2.4%)